The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Dose-dependent Blockade to Cardiomyocyte Hypertrophy by Histone Deacetylase Inhibitors
Open accessAbstract
Postnatal cardiac myocytes respond to stress signals by hypertrophic growth and activation of a fetal gene program. Recently, we showed that class II histone deacetylases (HDACs) suppress cardiac hypertrophy, and mice lacking the class II HDAC, HDAC9, are sensitized to hypertrophic signals. To further define the roles of HDACs in cardiac hypertrophy, we analyzed the effects of HDAC inhibitors on the responsiveness of primary cardiomyocytes to hypertrophic agonists. Paradoxically, HDAC inhibitors imposed a dose-dependent blockade to hypertrophy and fetal gene activation. We conclude that distinct HDACs play positive or negative roles in the control of cardiomyocyte hypertrophy. HDAC inhibitors are currently being tested in clinical trials as anti-cancer agents. Our results suggest that these inhibitors may also hold promising clinical value as therapeutics for cardiac hypertrophy and heart failure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
Imai, S.-I., Armstrong, C. M., Kaeberlein, M., & Guarente, L. (2000) · Nature · doi:10.1038/35001622 · Cited by 3,510
Histone deacetylases and cancer: causes and therapies
Marks, P. A., Rifkind, R. A., Richon, V. M., Breslow, R., Miller, T., & Kelly, W. K. (2001) · Nature reviews. Cancer · doi:10.1038/35106079 · Cited by 1,866
Yoshida, M., Kijima, M., Akita, M., & Beppu, T. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44885-x · Cited by 1,854
Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., Breslow, R., & Pavletich, N. P. (1999) · Nature · doi:10.1038/43710 · Cited by 1,714
Histone-deacetylase inhibitors: novel drugs for the treatment of cancer
Johnstone, R. W. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd772 · Cited by 1,515
Cardiac Hypertrophy: The Good, the Bad, and the Ugly
Frey, N., & Olson, E. N. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142243 · Cited by 1,449
Self-citationPhylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins
Frye, R. A. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3000 · Cited by 1,409
Histone Deacetylase Inhibitors: Inducers of Differentiation or Apoptosis of Transformed Cells
Marks, P. A., Richon, V. M., & Rifkind, R. A. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.15.1210 · Cited by 1,157
Class II Histone Deacetylases Act as Signal-Responsive Repressors of Cardiac Hypertrophy
Zhang, C. L., McKinsey, T. A., Chang, S., Antos, C. L., Hill, J. A., & Olson, E. N. (2002) · Cell · doi:10.1016/s0092-8674(02)00861-9 · Cited by 973
Self-citationThe silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases
Landry, J., Sutton, A., Tafrov, S. T., Heller, R. C., Stebbins, J., Pillus, L., & Sternglanz, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.110148297 · Cited by 970
Three proteins define a class of human histone deacetylases related to yeast Hda1p
Grozinger, C. M., Hassig, C. A., & Schreiber, S. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.9.4868 · Cited by 770
Fischle, W., Dequiedt, F., Hendzel, M. J., Guenther, M. G., Lazar, M. A., Voelter, W., & Verdin, E. (2002) · Molecular Cell · doi:10.1016/s1097-2765(01)00429-4 · Cited by 754
(2002) · PubMed · Cited by 732
MEF2: a calcium-dependent regulator of cell division, differentiation and death
McKinsey, T. A., Zhang, C. L., & Olson, E. N. (2002) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)02031-x · Cited by 687
Self-citationButler, L. M., Agus, D. B., Scher, H. I., Higgins, B., Rose, A., Cordon‐Cardo, C., Thaler, H. T., Rifkind, R. A., Marks, P. A., & Richon, V. M. (2000) · PubMed · Cited by 615
The Human Histone Deacetylase Family
Gray, S. G., & Ekström, T. J. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5080 · Cited by 546
CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo
Passier, R., Zeng, H., Frey, N., Naya, F. J., Nicol, R. L., McKinsey, T. A., Overbeek, P., Richardson, J. A., Grant, S. R., & Olson, E. N. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8551 · Cited by 521
Self-citationLu, J., McKinsey, T. A., Nicol, R. L., & Olson, E. N. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.080064097 · Cited by 518
Self-citationMyocardial Gene Expression in Dilated Cardiomyopathy Treated with Beta-Blocking Agents
Lowes, B. D., Gilbert, E. M., Abraham, W. T., Minobe, W. A., Larrabee, P., Ferguson, D., Wolfel, E. E., Lindenfeld, J., Tsvetkova, T., Robertson, A. D., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012630 · Cited by 501
Rockman, H. A., Chien, K. R., Choi, D.-J., Iaccarino, G., Hunter, J. J., Ross, J., Lefkowitz, R. J., & Koch, W. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.7000 · Cited by 489
Suppression of histone deacetylation in vivo and in vitro by sodium butyrate.
Boffa, L. C., Vidali, G., Mann, R. S., & Allfrey, V. G. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34804-4 · Cited by 478
Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo
Antos, C. L., McKinsey, T. A., Frey, N., Kutschke, W., McAnally, J., Shelton, J. M., Richardson, J. A., Hill, J. A., & Olson, E. N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231619298 · Cited by 477
Self-citationGlobal histone acetylation and deacetylation in yeast
Vogelauer, M., Wu, J., Suka, N., & Grunstein, M. (2000) · Nature · doi:10.1038/35044127 · Cited by 451
Vigushin, D. M., Ali, S., Pace, P., Mirsaidi, N., Ito, K., Adcock, I. M., & Coombes, R. C. (2001) · PubMed · Cited by 447
Glycogen Synthase Kinase-3β: A Novel Regulator of Cardiac Hypertrophy and Development
Hardt, S. E., & Sadoshima, J. (2002) · Circulation Research · doi:10.1161/01.res.0000018952.70505.f1 · Cited by 438
Genomewide studies of histone deacetylase function in yeast
Bernstein, B. E., Tong, J. K., & Schreiber, S. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.250477697 · Cited by 421
Second generation hybrid polar compounds are potent inducers of transformed cell differentiation.
Richon, V. M., Webb, Y., Merger, R., Sheppard, T., Jursic, B., Ngo, L., Civoli, F., Breslow, R., Rifkind, R. A., & Marks, P. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5705 · Cited by 420
Glycogen Synthase Kinase-3β Is a Negative Regulator of Cardiomyocyte Hypertrophy
Haq, S., Choukroun, G., Kang, Z. B., Ranu, H., Matsui, T., Rosenzweig, A., Molkentin, J. D., Alessandrini, A., Woodgett, J., Hajjar, R., et al. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.151.1.117 · Cited by 392
Sambucetti, L. C., Fischer, D. D., Zabludoff, S., Kwon, P. O., Chamberlin, H., Trogani, N., Xu, H., & Cohen, D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.34940 · Cited by 390
Esposito, G., Rapacciuolo, A., Naga Prasad, S. V., Takaoka, H., Thomas, S. A., Koch, W. J., & Rockman, H. A. (2002) · Circulation · doi:10.1161/hc0102.101365 · Cited by 377
Sartorelli, V., Huang, J., Hamamori, Y., & Kedes, L. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.2.1010 · Cited by 370
Huang, E. Y., Zhang, J., Miska, E. A., Guenther, M. G., Kouzarides, T., & Lazar, M. A. (2000) · Genes & Development · doi:10.1101/gad.14.1.45 · Cited by 325
Cardiac hypertrophy is not a required compensatory response to short-term pressure overload
Hill, J. A., Karimi, M., Kutschke, W., Davisson, R. L., Zimmerman, K., Wang, Z., Kerber, R. E., & Weiss, R. M. (2000) · Circulation · doi:10.1161/01.cir.101.24.2863 · Cited by 309
Histone deacetylase inhibitors in cancer treatment
Vigushin, D. M., & Coombes, R. C. (2002) · Anti-Cancer Drugs · doi:10.1097/00001813-200201000-00001 · Cited by 301
Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo
Rothermel, B. A., McKinsey, T. A., Vega, R. B., Nicol, R. L., Mammen, P., Yang, J., Antos, C. L., Shelton, J. M., Bassel-Duby, R., Olson, E. N., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041614798 · Cited by 294
Self-citationHarding, V. B., Jones, L. R., Lefkowitz, R. J., Koch, W. J., & Rockman, H. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091102398 · Cited by 255
Zhang, C. L., McKinsey, T. A., & Olson, E. N. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.20.7302-7312.2002 · Cited by 246
Self-citationGlycogen Synthase Kinase 3β Regulates GATA4 in Cardiac Myocytes
Morisco, C., Seta, K., Hardt, S. E., Lee, Y., Vatner, S. F., & Sadoshima, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103166200 · Cited by 232
Zhang, C. L., McKinsey, T. A., Lu, J.-R., & Olson, E. N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007364200 · Cited by 220
Self-citationBrosch, G., Ransom, R., Lechner, T., Walton, J. D., & Loidl, P. (1995) · The Plant Cell · doi:10.1105/tpc.7.11.1941 · Cited by 204
Protein modules that manipulate histone tails for chromatin regulation
Marmorstein, R. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35073047 · Cited by 203
Stockwell, B. R., Haggarty, S. J., & Schreiber, S. L. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(99)80004-0 · Cited by 202
Signaling chromatin to make muscle
McKinsey, T. A., Zhang, C. L., & Olson, E. N. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00389-7 · Cited by 198
Self-citationGusterson, R. J., Jazrawi, E., Adcock, I. M., & Latchman, D. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211762200 · Cited by 188
The emerging role of class II histone deacetylases
Fischle, W., Kiermer, V., Dequiedt, F., & Verdin, E. (2001) · Biochemistry and Cell Biology · doi:10.1139/bcb-79-3-337 · Cited by 181
Class II Histone Deacetylases Are Directly Recruited by BCL6 Transcriptional Repressor
Lemercier, C., Brocard, M.-P., Puvion-Dutilleul, F., Kao, H.-Y., Albagli, O., & Khochbin, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201736200 · Cited by 172
p300 Functions as a Coactivator of Transcription Factor GATA-4
Dai, Y.-S., & Markham, B. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103731200 · Cited by 166
Identification of a nuclear domain with deacetylase activity
Downes, M., Ordentlich, P., Kao, H., Alvarez, J. G. A., & Evans, R. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.19.10330 · Cited by 152
Calcineurin Plays a Critical Role in Pressure Overload–Induced Cardiac Hypertrophy
Shimoyama, M., Hayashi, D., Takimoto, E., Zou, Y., Oka, T., Uozumi, H., Kudoh, S., Shibasaki, F., Yazaki, Y., Nagai, R., et al. (1999) · Circulation · doi:10.1161/01.cir.100.24.2449 · Cited by 149
Histone Deacetylase in Carcinogenesis and Its Inhibitors as Anti-cancer Agents
Kim, D. H., Kim, M., & Kwon, H.-J. (2003) · BMB Reports · doi:10.5483/bmbrep.2003.36.1.110 · Cited by 123
Butler, L. M., Webb, Y., Agus, D. B., Higgins, B., Tolentino, T., Kutko, M. C., LaQuaglia, M. P., Drobnjak, M., Cordon‐Cardo, C., Scher, H. I., et al. (2001) · PubMed · Cited by 120
Anti-tumour activity in vitro and in vivo of selective differentiating agents containing hydroxamate
Qiu, L., Kelso, M. J., Hansen, C. P., West, M. L., Fairlie, D. P., & Parsons, P. G. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690493 · Cited by 115
Cohen, L. A., Amin, S., Marks, P. A., Rifkind, R. A., Desai, D. H., & Richon, V. M. (1999) · PubMed · Cited by 112
Kuwahara, K., Saito, Y., Ogawa, E., Takahashi, N., Nakagawa, Y., Naruse, Y., Harada, M., Hamanaka, I., Izumi, T., Miyamoto, Y., et al. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.6.2085-2097.2001 · Cited by 108
Structure of Histone Deacetylases
Marmorstein, R. (2001) · Structure · doi:10.1016/s0969-2126(01)00690-6 · Cited by 97
Fiber-derived butyrate and the prevention of colon cancer
Hassig, C. A., Tong, J. K., & Schreiber, S. L. (1997) · Chemistry & Biology · doi:10.1016/s1074-5521(97)90111-3 · Cited by 87
Morphological reversion of sis-transformed NIH3T3 cells by trichostatin A.
Sugita, K., Koizumi, K., & Yoshida, H. (1992) · PubMed · Cited by 54
Adolph, E., Subramaniam, A., Cserjesi, P., Olson, E. N., & Robbins, J. M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53326-3 · Cited by 50
Self-citation
Cited by
Haberland, M., Montgomery, R. L., & Olson, E. N. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2485 · Cited by 2,526
Self-citationHistone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility
Montgomery, R. L., Davis, C. A., Potthoff, M. J., Haberland, M., Fielitz, J., Qi, X., Hill, J. A., Richardson, J. A., & Olson, E. N. (2007) · Genes & Development · doi:10.1101/gad.1563807 · Cited by 712
Self-citationChang, S., McKinsey, T. A., Zhang, C. L., Richardson, J. A., Hill, J. A., & Olson, E. N. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.19.8467-8476.2004 · Cited by 613
Self-citationVega, R. B., Harrison, B. C., Meadows, E., Roberts, C. R., Papst, P. J., Olson, E. N., & McKinsey, T. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.19.8374-8385.2004 · Cited by 511
Self-citationChromatin regulation by Brg1 underlies heart muscle development and disease
Hang, C. T., Yang, J., Han, P., Cheng, H.-L., Shang, C., Ashley, E., Zhou, B., & Chang, C.-P. (2010) · Nature · doi:10.1038/nature09130 · Cited by 470
Metadata
- Authors
- Antos, C. L., McKinsey, T. A., Dreitz, M., Hollingsworth, L. M., Zhang, C.-L., Schreiber, K., Rindt, H., Gorczynski, R. J., & Olson, E. N.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-08
- Volume
- 278
- Issue
- 31
- Pages
- 28930-28937
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2021860877
- Cited by
- 269
- References
- 59
- FWCI
- 4.40
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.